141 related articles for article (PubMed ID: 19440084)
1. Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy.
Desai S; Khanani S; Shad MU; Brown ES
J Clin Psychopharmacol; 2009 Jun; 29(3):284-7. PubMed ID: 19440084
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.
Brown ES; Wolfshohl J; Shad MU; Vazquez M; Osuji IJ
Neuropsychopharmacology; 2008 Sep; 33(10):2376-83. PubMed ID: 18004283
[TBL] [Abstract][Full Text] [Related]
3. Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.
Brown ES; Zaidel L; Allen G; McColl R; Vazquez M; Ringe WK
J Affect Disord; 2010 Nov; 126(3):415-9. PubMed ID: 20580827
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.
Brown ES; Sayed N; Choi C; Tustison N; Roberts J; Yassa MA; Van Enkevort E; Nakamura A; Ivleva EI; Sunderajan P; Khan DA; Vazquez M; McEwen B; Kulikova A; Frol AB; Holmes T
Eur Neuropsychopharmacol; 2019 Mar; 29(3):376-383. PubMed ID: 30612854
[TBL] [Abstract][Full Text] [Related]
5. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids.
Brown ES; Frol A; Bobadilla L; Nejtek VA; Perantie DC; Dhillon H
Psychosomatics; 2003; 44(3):204-8. PubMed ID: 12724501
[TBL] [Abstract][Full Text] [Related]
6. Effect of two prednisone exposures on mood and declarative memory.
Brown ES; Beard L; Frol AB; Rush AJ
Neurobiol Learn Mem; 2006 Jul; 86(1):28-34. PubMed ID: 16458545
[TBL] [Abstract][Full Text] [Related]
7. Amygdala volume in patients receiving chronic corticosteroid therapy.
Brown ES; Woolston DJ; Frol AB
Biol Psychiatry; 2008 Apr; 63(7):705-9. PubMed ID: 17981265
[TBL] [Abstract][Full Text] [Related]
8. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
10. Acute neural effects of the mood stabiliser lamotrigine on emotional processing in healthy volunteers: a randomised control trial.
Martens MAG; Zghoul T; Watson E; Rieger SW; Capitão LP; Harmer CJ
Transl Psychiatry; 2024 May; 14(1):211. PubMed ID: 38802372
[TBL] [Abstract][Full Text] [Related]
11. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy.
Brown ES; Stuard G; Liggin JD; Hukovic N; Frol A; Dhanani N; Khan DA; Jeffress J; Larkin GL; McEwen BS; Rosenblatt R; Mageto Y; Hanczyc M; Cullum CM
Biol Psychiatry; 2005 Mar; 57(5):543-8. PubMed ID: 15737670
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
Belsito KM; Law PA; Kirk KS; Landa RJ; Zimmerman AW
J Autism Dev Disord; 2001 Apr; 31(2):175-81. PubMed ID: 11450816
[TBL] [Abstract][Full Text] [Related]
14. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.
Brown ES; J Woolston D; Frol A; Bobadilla L; Khan DA; Hanczyc M; Rush AJ; Fleckenstein J; Babcock E; Cullum CM
Biol Psychiatry; 2004 Mar; 55(5):538-45. PubMed ID: 15023583
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine in the treatment of bipolar depression.
Bowden CL; Mitchell P; Suppes T
Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S113-7. PubMed ID: 10524837
[TBL] [Abstract][Full Text] [Related]
17. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
Ettinger AB; Kustra RP; Hammer AE
Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
[TBL] [Abstract][Full Text] [Related]
19. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine and the treatment of mania in bipolar disorder.
Berk M
Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S119-23. PubMed ID: 10524838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
